Neoadjuvant chemoradiotherapy with sequential ipilimumab and nivolumab in rectal cancer (CHINOREC): A prospective randomized, open-label, multicenter, phase II clinical trial

Johannes Laengle; Irene Kührer; Dietmar Pils; Julijan Kabiljo; J Stift; Friedrich Herbst; Bernhard Dauser; Matthias Monschein; Peter Razek; Reinhold Függer; null et al.

doi:10.1200/JCO.2021.39.15_suppl.TPS3623

Neoadjuvant chemoradiotherapy with sequential ipilimumab and nivolumab in rectal cancer (CHINOREC): A prospective randomized, open-label, multicenter, phase II clinical trial

Johannes Laengle, Irene Kührer, Dietmar Pils, Julijan Kabiljo, J Stift, Friedrich Herbst, Bernhard Dauser, Matthias Monschein, Peter Razek, Reinhold Függer, et al.

Faculty of Medicine

Research output: Contribution to journal › Article › peer-review

Original language	English
Number of pages	1
Journal	Journal of Clinical Oncology
Volume	39
DOIs	https://doi.org/10.1200/JCO.2021.39.15_suppl.TPS3623
Publication status	Published - May 2021

Fields of science

303 Health Sciences
304 Medical Biotechnology
305 Other Human Medicine, Health Sciences
301 Medical-Theoretical Sciences, Pharmacy
302 Clinical Medicine

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1200/JCO.2021.39.15_suppl.TPS3623

Cite this

Laengle, J., Kührer, I., Pils, D., Kabiljo, J., Stift, J., Herbst, F., Dauser, B., Monschein, M., Razek, P., Függer, R., & et al. (2021). Neoadjuvant chemoradiotherapy with sequential ipilimumab and nivolumab in rectal cancer (CHINOREC): A prospective randomized, open-label, multicenter, phase II clinical trial. Journal of Clinical Oncology, 39. https://doi.org/10.1200/JCO.2021.39.15_suppl.TPS3623

@article{08f0cdceee6f4ff48695520224e0f593,

title = "Neoadjuvant chemoradiotherapy with sequential ipilimumab and nivolumab in rectal cancer (CHINOREC): A prospective randomized, open-label, multicenter, phase II clinical trial",

author = "Johannes Laengle and Irene K{\"u}hrer and Dietmar Pils and Julijan Kabiljo and J Stift and Friedrich Herbst and Bernhard Dauser and Matthias Monschein and Peter Razek and Reinhold F{\"u}gger and {et al.}",

year = "2021",

month = may,

doi = "10.1200/JCO.2021.39.15_suppl.TPS3623",

language = "English",

volume = "39",

journal = "Journal of Clinical Oncology",

issn = "1527-7755",

}

Laengle, J, Kührer, I, Pils, D, Kabiljo, J, Stift, J, Herbst, F, Dauser, B, Monschein, M, Razek, P, Függer, R & et al. 2021, 'Neoadjuvant chemoradiotherapy with sequential ipilimumab and nivolumab in rectal cancer (CHINOREC): A prospective randomized, open-label, multicenter, phase II clinical trial', Journal of Clinical Oncology, vol. 39. https://doi.org/10.1200/JCO.2021.39.15_suppl.TPS3623

TY - JOUR

T1 - Neoadjuvant chemoradiotherapy with sequential ipilimumab and nivolumab in rectal cancer (CHINOREC): A prospective randomized, open-label, multicenter, phase II clinical trial

AU - Laengle, Johannes

AU - Kührer, Irene

AU - Pils, Dietmar

AU - Kabiljo, Julijan

AU - Stift, J

AU - Herbst, Friedrich

AU - Dauser, Bernhard

AU - Monschein, Matthias

AU - Razek, Peter

AU - Függer, Reinhold

AU - et al., null

PY - 2021/5

Y1 - 2021/5

U2 - 10.1200/JCO.2021.39.15_suppl.TPS3623

DO - 10.1200/JCO.2021.39.15_suppl.TPS3623

M3 - Article

SN - 1527-7755

VL - 39

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

ER -